Clinical Trial Update: Fludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Patients With Hematological Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating fludarabine, busulfan, and anti-lymphocyte globulin followed by donor stem cell transplant in older patients with hematologic cancers; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Multiple Myeloma
• Myelodysplastic Myelodysplastic Neoplasms
• Myelodysplastic Syndromes
• Myeloproliferative Neoplasms

Drugs mentioned

• Antilymphocyte Globulin (Antilymphocyte Globulin)
• BUSULFAN (Busulfan)
• Fludarabine (Fludarabine)

Snippet

Sponsor: Institut Paoli-Calmettes | Conditions: Chronic Myeloproliferative Disorders, Leukemia | Phase 2 | Status: COMPLETED